IRCT20171219037964N3招募中3 期
Study the effect of Favipiravir on the outpatient treatment Covid-19 patients
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •definite case of Covid-19
- •age over 18
- •presented within 5 days from the start of sign and symptoms
排除标准
- •severe cases with SpO2 under 90
- •using an antiviral in previous two weeks
- •previous infection with covid-19
- •using an steroid in previous two weeks
- •being under treatment with steroid
- •previous allergic to Favipiravir
- •renal failure
- •hepatic failure
研究者
相似试验
已完成
不适用
Investigation on the effect of favipiravir in preventing Ebola virus disease and its safetyEbola virus diseaseJPRN-UMIN000016102ational Center for Global Health and Medicine25
招募中
3 期
The therapeutic effect of Favipiravir in COVID-19 patientsIRCT20211004052664N1Shahid Beheshti University of Medical Sciences80
招募中
3 期
Evaluation the effects of Favipiravir in COVID-19 patientsCOVID-19 pneumonia.COVID-19, virus identifiedU07.1IRCT20151227025726N14Shahid Beheshti University of Medical Sciences84
已完成
不适用
The Real-world Clinical Outcomes of Favipiravir Treatment in Mild to Moderate COVID-19 Patients in Single Outpatient Visit Followed by Home Isolation: a Multicenter, case-control StudyTCTR20221113004Chulabhorn Royal Academy1,037
已完成
3 期
Favipiravir effectiveness in patients undergoing COVID19 Acute respiratory distress syndrome (ARDS)covid positive.Coronavirus infection, unspecifiedB34.2IRCT20150107020592N26Masih Daneshvari Hospital20